•  
  • New York 03:49
  • London 07:49
  • Barcelona 08:49
  • Tokyo 16:49
  • Sydney 18:49
  • SignUp | Login

Technical Trader Closing Brief

Surging Markets Disregard Negative Divergences and Overbought Oscillators

Fri, Jul 24 2009, 06:07 GMT
by Harry Boxer

The Technical Trader  |  View company's profile


Vote:

6

0

The market had an extremely strong session on Thursday, and the rally rolls on.

The day started out with a move up off the opening, and just accelerated from there, reaching the session highs around early afternoon. They pulled back to test the intraday moving averages successfully, and then moved back up to retest the highs, creating doubletops at 1605 NDX and just under 980 SPX. In the last half hour or so they gave back a bit of it, but still closed strong.

Net on the day the Dow was up over 188 points at 9069.29, the S&P 500 up 22.22 at 976.29, and the Nasdaq 100 up 36.52 at 1601.52.

Advance-declines were better than 5 to 1 positive on New York and about 3 ½ to 1 positive on Nasdaq.
Up/down volume was more than 1.1 billion to the upside and 225 million to the downside, about 4 ½ to 1 positive, on New York. Nasdaq traded a heavy 3 billion shares and had an almost 5 to 1 positive volume ratio.

TheTechTrader.com board was nearly all higher, except for the ultrashorts and for STEC Inc. (STEC), which dropped 1.39 on profit-taking, after reaching a new all-time high earlier in the day.

On the plus side, Potash (POT) was up 6.85 at 95.78, and Mosaic (MOS) up 3.03 to 51.45, as ag/chem stocks were very strong.

Among financial stocks, Goldman Sachs (GS) advanced 4.99 at 165.45, JP Morgan (JPM) was up 1.32 at 38.15, and Morgan Stanley (MS) up 1 at 28.54, although Wells Fargo (WFC) actually lost 19 cents to 24.26.

The junior biotech group was generally very strong today. Dendreon (DNDN) gained 1.43 to 24.47 and BioCryst Pharmaceuticals (BCRX) 78 cents to 8.59.
Incyte Pharmaceuticals (INCY) at 5.32 was up 89 cents, and Chart of the Day OncoGenex

Pharmaceuticals (OGXI) jumped to 27.55, a new multi-year high, but gave back a bit, still up 63 cents at the close to 26.50. Savient Pharmaceuticals (SVNT) gained 58 cents at 15.40, and Vanda Pharmaceuticals (VNDA) 80 cents to 14.80.

On the downside, the Direxion Financial Bear 3x Shares (FAZ) lost 3.22 to 38.63 on nearly 50 million traded, and the Direxion Small Cap 3x Bear (TZA) dropped 1.98 to 17.55. The UltraShort Real Estate ProShares (SRS) lost 1.42 to 16.73, and the Direxion Large Cap Bear 3X Shares (BGZ) dropped 2.14 to 28.58.

Among the ETF's today: The Oil Services ETF (OIH) gained 3.66 to 105.95, the iShares FTSE/Xinhua China 25 Index (FXI) 1.64 to 42.06, and the iShares MSCI Brazil Index ETF (EWZ) up 1.51 at 56.92.The U.S. Oil Fund ETF (USO) gained 98 cents to 35.79 on firmer oil.

Stepping back and reviewing the hourly chart patterns, up from the get-go, strong rally today, and then some afternoon backing and filling, but not much damage, as the indices closed with very strong gains. At this point, the oscillators are extremely overbought. Within the next day or two, we're expecting a pullback/retest at the very least and probably something much steeper. The markets continue to press higher, disregarding all negative divergences & oscillators, but we'll see if that changes shortly.


AdviceTrade, Inc. | 1611 South Catalina Avenue, Suite 201, Redondo Beach, CA 90277
http://www.thetechtrader.com/ | info@thetechtrader.com

Archive


Legal disclaimer and risk disclosure

In using any portion of The Technical Trader, you agree to the Terms and Conditions governing the use of the service as described in this disclaimer. Our disclaimers, policies and terms are subject to change without notice. The Technical Trader (www.thetechtrader.com) is published by Century-Pacific Investments and AdviceTrade, Inc., both of which are publishers. The Web site is maintained by Codexia, LLC. None of these firms, nor Mr. Boxer, is registered as a broker-dealer or investment adviser either with the U.S. Securities and Exchange Commission or with any state securities authority. Each trade mentioned in the diary and other sections of The Technical Trader is hypothetical and is not an actual trade. Mr. Boxer and employees of Century-Pacific, AdviceTrade and Codexia are not allowed to have personal positions in stocks mentioned in the diary and other sections of The Technical Trader. This policy, first announced to subscribers on June 2, 2004, gave Mr. Boxer a deadline that was extended to July 30, 2004 for liquidating any existing personal holdings in stocks mentioned on the site. Our holdings page, in which Mr. Boxer listed his personal positions in stocks mentioned on the site, was removed at that time. The publishers are not permitted to have any financial relationship with companies mentioned on the site. Mr. Boxer may recommend trades of stocks mentioned in the Diary as a consultant to hedge funds, but has agreed not to make such recommendations until after the stock has been posted on The Technical Trader Web site. Mr. Boxer's commentaries, trading ideas and model trades represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Neither we nor Mr. Boxer claim to have any non-public information regarding the companies mentioned in this site. The trade prices that appear on this Web site are based on the average of the real-time bid and real-time ask prices provided by Money.net, except when entered manually by Mr. Boxer should Money.net's feed be temporarily down. There may be a delay between the price as it appears in the diary and the current price that you see from your terminal due to delays in Internet connectivity, quote delays, refresh intervals in the case of the Web-based diary page, data entry errors, and market conditions, and also due to times when Mr. Boxer is not available to make the trade at the moment a previously stated target has been met. Entries may at times be in error due to system or data-entry errors. Hypothetical performance results do not include trading commissions and other execution costs that would be incurred if the trades referenced in the diary or elsewhere on the site were actual trades. Past performance is no guarantee of future results.
Vote:

6

0

Related reports

Greece the Skids by Alaron
Mon, Mar 22 2010, 05:36 GMT

Recent Recommended Trades by AceTrader
Mon, Mar 22 2010, 04:29 GMT

Dollar Up as Stocks fall by Easy Forex
Mon, Mar 22 2010, 03:54 GMT

Market Morning Briefing by Kshitij Consultancy Services
Mon, Mar 22 2010, 03:37 GMT

Forex Market Outlook on Majors by AceTrader
Mon, Mar 22 2010, 03:12 GMT

eurusd, eurjpy, chfjpy, gbpusd, usdchf, equities, stocks, gbpjpy, dowjones, usdjpy

[ View All ]

Related content

Forex: EUR/USD testing 1.3500 support at European opening
FXstreet.com | Mon, Mar 22 2010, 07:37 GMT

Forex: USD/JPY stretches higher to test 90.70/80 high
FXstreet.com | Mon, Mar 22 2010, 07:25 GMT

Asian markets drop with Greece debt looming; Euro and Pound, weak
FXstreet.com | Mon, Mar 22 2010, 07:10 GMT

GBP/USD fall is limited by 1.4936
FXstreet.com | Mon, Mar 22 2010, 05:02 GMT

Stops to blame for fall in cable
Forex Live | Mon, Mar 22 2010, 04:17 GMT

eurusd, eurjpy, chfjpy, gbpusd, usdchf, equities, stocks, gbpjpy, dowjones, usdjpy

[ View All ]

Note: All information on this page is subject to change. The use of this website constitutes acceptance of our user agreement. Please read our privacy policy and legal disclaimer.

Trading foreign exchange on margin carries a high level of risk and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to trade foreign exchange you should carefully consider your investment objectives, level of experience and risk appetite. The possibility exists that you could sustain a loss of some or all of your initial investment and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with foreign exchange trading and seek advice from an independent financial advisor if you have any doubts.

Opinions expressed at FXstreet.com are those of the individual authors and do not necessarily represent the opinion of FXstreet.com or its management. FXstreet.com has not verified the accuracy or basis-in-fact of any claim or statement made by any independent author: errors and Omissions may occur.

Any opinions, news, research, analyses, prices or other information contained on this website, by FXstreet.com, its employees, partners or contributors, is provided as general market commentary and does not constitute investment advice. FXstreet.com will not accept liability for any loss or damage, including without limitation to, any loss of profit, which may arise directly or indirectly from use of or reliance on such information.

©2010 "FXstreet.com. The Forex Market" All Rights Reserved.